// App-Quantinova.ai

: Home nasal high-flow following severe COPD exacerbation: a mixed-methods feasibility randomised controlled trial

Researchers

Presenter

  • Rebecca D'Cruz

Principal Investigators

  • Anne Rossel

  • Eui-Sik Suh

  • Georgios Kaltsakas

  • Neeraj Shah

  • Amy Dewar

  • Louise Rose

  • Patrick Murphy

  • Nicholas Hart

Medical Centers

  • Medical Oncology Department, Guys and St. Thomas NHS Foundation Trust, London, United Kingdom

  • Lane Fox Clinical Respiratory Physiology Research Unit, Guy's and St Thomas' NHS Foundation Trust and Department of Internal Medicine, Geneva University Hospitals, London, United Kingdom

  • Lane Fox Respiratory Services and Lane Fox Clinical Respiratory Physiology Research Centre, Guy’s and St Thomas’ Hospital NHS Foundation Trust, SE1 7EH, London, UK. Faculty of Life Sciences and Medicine, King’s College London, WC2R 2LS, London, United Kingdom

  • Lane Fox Clinical Respiratory Physiology Research Unit, Guy's and St Thomas' NHS Foundation Trust and Centre for Human and Applied Physiological Sciences, King’s College London, London, United Kingdom

  • Florence Nightingale Faculty of Nursing, Midwifery and Palliative Care, King’s College London, London, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • Catalase

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • III

Study Id's

  • ISRCTN15949009

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved